FLUOXETINE ALTERS MU OPIOID RECEPTOR EXPRESSION IN OBESE ZUCKER RAT EXTRAHYPOTHALAMIC REGIONS

REFERENCES

• Belluzi J. D., Stein L. L. Enkephalin may mediate euphoria and drive-reduction reward. Nature 1977; 266: 556–558, [CSA]
   PubMedGoogle Scholar
• Berridge K. C. Food reward: brain substrates of wanting and liking. Neuroscience Biobehavioral Review 1996; 20(1)1–25, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chen X., Marrero H. G., Freedman J. E. Opioid receptor modulation of a metabolically sensitive ion channel in rat amygdala neurons. Journal of Neuro-science 2001; 21(23)9092–90100, [CSA]
   Google Scholar
• Churruca I., Casis L., Portillo M. P., Macarulla M. T., Zárate J., Pascual J., Echevarria E. Fluoxetine alters mu opioid receptor expression in obese Zucker rat hypothalamus. Neurosci Res Comm. 2004; 35(1), (in press). Published Online: 17 Aug 2004[CSA], [CROSSREF]
   Google Scholar
• Cole J. L., Berman N., Bodnar R. J. Evaluation of chronic opioid receptor antagonist effects upon weight and intake measures in lean and obese Zucker rats. Peptides 1997; 18(8)1201–1207, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• De Felipe M. C., De Ceballos M. L., Gil C., Fuentes J. A. Chronic antidepressant treatment increases enkephalin levels in nucleus accumbens and striatum of the rat. European Journal of Pharmacology. 1985; 112: 119–122, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• De Felipe M. C., De Ceballos M. L., Gil C., Fuentes J. A. Hypoalgesia induced by antidepressant in mice: A case for opioids and serotonin. European Journal of Pharmacology 1986; 125: 193–199, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Ding Y. Q., Kaneko T., Nomura S., Mizuno N. Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat. Journal of Comp Neuroloyg 1996; 367(3)375–402, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Eschalier A., Montasturc J. L., Devoize J. L., Rigal F., Gaillard-Plaza G., Pechadre J. C. Influence of naloxone and metisergide on the analgesic effect of clomipramine in rats. European Journal of Pharmacology 1981; 76: 1–7, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Gandarias J. M., Echevarría E., Acebes I., Silió M., Casis L. Effects of imipramine administration on mu-opioid receptor immunostaining in the rat fore-brain. Arzneim-Forsch/Drug Research 1998; 48(II)717–719, [CSA]
   PubMedGoogle Scholar
• Gandarias J. M., Echevarría E., Acebes I., Abecia L. C., Casis O., Casis L. Effects of fluoxetine administration on mu-opioid receptor immunostaining in the rat forebrain. Brain Research 1999; 817: 236–240, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Glass M. J., Billington C. J., Levine A. S. Opioids and food intake: Distributed functional neural pathways?. Neuropeptides 1999; 33(5) 360–368, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Goldstein D. J., Hamilton S. H., Masica D. N., Beasley C. M. Fluoxetine in medically stable, depressed geriatric patients: Effect on weight. Journal of Clinical Psychopharmacology 1997; 17 365–369, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hiller J. M., Zhang Y., Bing T., Gioannini T. L., Stone E. A., Simon E. J. Immunohistochemical localization of mu-opioid receptors in rat brain using antibodies generated against a peptide sequence present in a purified mu-opioid binding protein. Neuroscience. 1994; 62: 829–841, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Humel T., Humel C., Friedel Y., Pauli E., Kobal G. A comparison of the antinociceptive effects of imipramine, tramadol and anpirtoline. British Journal of Clinical Pharmacology 1994; 37 325–333, [CSA]
   PubMedGoogle Scholar
• Jarosz P. A., Metzger B. L. The effect of opioid antagonism on food intake behavior and body weight in a biobehavioral model of obese binge eating. Biological Research Nurs 2002; 3(4)198–209, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Kaneko T., Minami M., Satoh M., Mizuno N. Immunocytochemical localization of mu-opioid receptor in the rat caudate-putamen. Neuroscience Letters 1995; 184(3)149–152, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Koch J. E., Glass M. J., Cooper M. L., Bodnar R. J. Alterations in deprivation, glucoprivic and sucrose intake following general, mu and kappa opioid antagonists in the hypothalamic paraventricular nucleus of rats. Neuroscience 1995; 66(4)951–957, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kurumaji A., Mitsushio H., Takashima M. Chronic dietary treatment with antidepressants decrease brain met-enkephalin-like immunoreactivity in the rat. Psychopharmacology 1988; 94: 188–192, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Levine A. S., Olszewski P. K., Mullett M. A., Pomonis J. D., Grace M. K., Kotz C. M., Billington C. J. Intra-amygdalar injection of DAMGO: Effects on c-Fos levels in brain sites associated with feeding behavior. Brain Research 2004; 1015(1–2)9–14, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Mackay F. J., Dunn N R., Wilton L V., Pierce G L., Freemantle S. N., Mann R. D. A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiol Drug Safe 1997; 6: 235–246, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Marin-Bivens C. L., Olster D. H. Opioid receptor blockade promotes weight loss and improves the display of sexual behaviors in obese Zucker female rats. Pharmacol Biochem Behav 1999; 63(3)515–520, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Mitch C. H., Leander J. D., Mendelsohn L. G., Shaw W. N., Wong D. T., Cantrell B. E., Johnson B. G., Reel J. K., Snoddy J. D., Takemori A. E. 3,4-Dimethyl-4-(3-hydroxyphenyl)piperidines: Opioid antagonists with potent anorectant activity. Journal of Med Chem 1993; 36(20)2842–2850, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Pecina S., Berridge K. C. Central enhancement of taste pleasure by intraventricular morphine. Neurobiology 1995; 3: 269–280, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Roane D. S., Iadarola M. J., Porter J. R. Decreased [3H]-naloxone binding and elevated dynorphin-A(1-8) content in Zucker rat brain. Physiol Behav 1988; 43(3)371–374, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Smith S. L., Harrold J. A., Williams G. Diet-induced obesity increases mu opioid receptor binding in specific regions of the rat brain. Brain Research 2002; 953(1–2)215–222, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tura B., Tura S. The analgesic effect of tryciclic antidepressants. Brain Research 1990; 518: 19–22, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Valverde O., Micó J. A., Maldonado R., Mellado M., Gibert-Rahola J. Participation of opioid and monoaminergic mechanisms on the antinociceptive effect induced by tricyclic antidepressants in two behavioural pain test in mice. Prog Neuropsychopharmacol Biol Psychiatry. 1994; 18: 1073–1092, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Wong D. T., Bymaster F P., Englemam E. A. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Science 1995; 57: 411–441, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Yeomans M. R., Gray R. W. Opioid peptides and the control of human ingestive behaviour. Neuroscience Biobehavioral Reviews 2002; 26: 713–728, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar